|
|
|
|
| LEADER |
02806nmm a2200685 u 4500 |
| 001 |
EB002165786 |
| 003 |
EBX01000000000000001303565 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230607 ||| eng |
| 020 |
|
|
|a 9780841219502
|
| 050 |
|
4 |
|a RS201.C64
|
| 100 |
1 |
|
|a Dinh, Steven M.
|e [editor]
|
| 245 |
0 |
0 |
|a Advances in controlled drug delivery
|b science, technology, and products
|c Steven M. Dinh, Puchun Liu, editors
|
| 260 |
|
|
|a Washington, DC
|b American Chemical Society
|c 2003, 2003
|
| 300 |
|
|
|a 172 pages
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Metalloproteases / genetics
|
| 653 |
|
|
|a Delayed-Action Preparations
|
| 653 |
|
|
|a Genetic Engineering
|
| 653 |
|
|
|a Oligonucleotide Array Sequence Analysis
|
| 653 |
|
|
|a Heparin
|
| 653 |
|
|
|a MEDICAL / Pharmacology / bisacsh
|
| 653 |
|
|
|a Drug delivery systems
|
| 653 |
|
|
|a Colloids / therapeutic use
|
| 653 |
|
|
|a Cardiovascular Diseases / drug therapy
|
| 653 |
|
|
|a Tissue engineering
|
| 653 |
|
|
|a Heparin / Controlled release
|
| 653 |
|
|
|a Polymeric drug delivery systems
|
| 653 |
|
|
|a Peptides / Therapeutic use
|
| 653 |
|
|
|a Drug resistance / Prevention / Technological innovations
|
| 653 |
|
|
|a DNA microarrays / Therapeutic use
|
| 653 |
|
|
|a Metalloproteinases / Genetic engineering
|
| 653 |
|
|
|a Peptides / therapeutic use
|
| 653 |
|
|
|a Drug Resistance
|
| 653 |
|
|
|a Lung Diseases / therapy
|
| 653 |
|
|
|a Gene Therapy
|
| 653 |
|
|
|a Lungs / Diseases / Treatment
|
| 653 |
|
|
|a Gene therapy
|
| 653 |
|
|
|a Drug Delivery Systems / methods
|
| 653 |
|
|
|a Tissue Engineering
|
| 653 |
|
|
|a Cardiovascular Agents / pharmacology
|
| 653 |
|
|
|a Micelles
|
| 653 |
|
|
|a Drug Delivery Systems
|
| 653 |
|
|
|a Macromolecules / Therapeutic use / Methodology
|
| 653 |
|
|
|a Crosslinked polymers / Therapeutic use
|
| 653 |
|
|
|a Colloids / Therapeutic use / Methodology
|
| 653 |
|
|
|a Drugs / Controlled release
|
| 653 |
|
|
|a Micelles / Therapeutic use
|
| 653 |
|
|
|a Cardiovascular pharmacology
|
| 653 |
|
|
|a Macromolecular Substances / therapeutic use
|
| 700 |
1 |
|
|a Liu, Puchun
|e [editor]
|
| 710 |
2 |
|
|a American Chemical Society
|b Division of Polymeric Materials: Science and Engineering
|
| 710 |
2 |
|
|a American Chemical Society
|b Meeting ( 2001, San Diego, California)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ACS
|a ACS Symposium Series
|
| 490 |
0 |
|
|a ACS symposium series
|
| 500 |
|
|
|a "Result of a symposium entitled Advances in Controlled Drug Delivery held during the American Chemical Society (ACS) National Meeting in San Diego, California, in April 2001.". - Distributed in print by Oxford University Press
|
| 856 |
4 |
0 |
|u https://pubs.acs.org/doi/book/10.1021/bk-2003-0846
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615/.6
|